Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Drug Monitoring|November 10, 2017
Comparison of Antifactor Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Vascular Surgery Patients: A Single-Center Retrospective StudyElsie Rizk, Allison D Wilson, Michelle U Murillo, et al.
Research in Social & Administrative Pharmacy : RSAP|October 25, 2016
Discharge medication complexity and 30-day heart failure readmissionsA Carmine Colavecchia, David R Putney, Michael L Johnson, et al.
American Heart Journal|December 5, 2009
Impact of computerized dosing on eptifibatide-associated bleeding and mortalityDavid R Putney, Neal S Kleiman, Robert E Fromm, et al.
Therapeutic Drug Monitoring|June 6, 2014
Comparison of anti-Xa and activated partial thromboplastin time monitoring for heparin dosing in patients with cirrhosisAmaris Fuentes, Sherilyn Gordon-Burroughs, Jeffrey B Hall, et al.
British Journal of Nursing (Mark Allen Publishing)|July 20, 2022
Alteplase for the treatment of midline catheter occlusions: a retrospective, single-cohort descriptive studyElsie Rizk, Anh Thu Tran, Frank Soto, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 21, 2015
Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients With Morbid ObesityNathaniel R Thompson-Moore, Matthew A Wanat, David R Putney, et al.
Pageof 1